Ashley Clarke, Senior Medical Analyst at GlobalData said that blood-based biomarker tests that are cost-effective and ...

The ROS-1 NSCLC current market is mainly dominated by tyrosine kinase inhibitors such as XALKORI at present and is ...

Ashley Clarke, Senior Medical Analyst at GlobalData said that blood-based biomarker tests that are cost-effective and efficient in early assessment, have taken a major leap forward in diagnostics with ...

The method employs ultrathin membranes to capture small packets of cellular material known as extracellular vesicles. Cells ...

These studies provide data supporting the utility of seven renal biomarkers in safety testing in the preclinical setting. They have now been formally accepted by the US and European regulatory ...

Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that the ...

BioMark Strengthens Liquid Biopsy Platform for Breast Cancer Detection Vancouver, British Columbia--( - November 5, 2024) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCMKTS: BMKDF) ("BioMark"), ...

Diagnosis of Alzheimer’s Disease (AD) is currently largely based on the presence of biomarkers. This may lead to a problematic over-diagnosis if this is incorrectly interpreted.

IBS has classically been regarded as a “diagnosis of exclusion,” but new research suggested that might be changing with better diagnostic and treatment approaches.

New Appointment of Isaac Ro to Board of Directors Brings Broad Diagnostic Industry & Operations Experience to Company –SAN MATEO, Calif., ...

Stocks surged, Treasury yields soared, and the US dollar looked set for its biggest gain since March 2020 as early returns ...